Biotechnology

Biotechnology Industry Highlights

WHY INDIA?

• Biotechnology is a collection of technologies that capitalize on the attributes of cells, and put biological molecules such as DNA and proteins to work for us.
• A few of the biotechnologies that use cells and biological molecules find applications in:
  • Medicine
  • Agriculture
  • Food Processing
  • Industrial Manufacturing
  • Environmental Management
• ‘New’ biotechnologies are:
  • Bio-processing Technology
  • Monoclonal Antibodies
  • Cell Culture: including Plant Cell, Insect Cell, and Mammalian Cell culture
  • Recombinant DNA Technology
  • Cloning
  • Molecular Cloning: including Cellular and Animal cloning
  • Protein Engineering
  • Biosensors
  • Nanobiotechnology
  • Microarrays: including DNA, Protein, Tissue, Whole-Cell, and Small-Molecular microarrays
  • Bioinformatics
• The pharmaceutical industry, stands to benefit as much as other industries from off shoring opportunities since its real value lies not just in simple cost savings but also in the faster development of new compounds and a greater focus for sales and marketing organizations. Thus, the benefits could span across the entire value chain, from R&D through manufacturing and sales adding huge values, often several hundred million dollars.
• Low labor costs also offer the prospect of more efficient and successful clinical trials which form a very high content of a new drug’s development cost and over two-thirds of the trials miss their deadlines because they cant recruit patients quickly enough. Substantial cost savings can result by broadening the base of patients and physicians to include lower-cost countries.
• Data management and bioinformatics functions are rapidly going global, though the US and EU continue to carry out the higher-end functions of biostatistics and biometrics.
• India is also the top spot for outsourcing R&D operations ranging from chemistry services to data management to clinical trials.
• It is estimated that by the year 2010, the pharma industry in India has the potential to achieve Rs. 1,00,000 crores (US $2.2 billion) in revenues from formulations with bulk drug production at Rs. 25,000 crores (US $0.5 billion).
• A number of Government of India sponsored/owned R&D organizations are active in conducting and facilitating relevant research in this sector viz. Indian Council of Medical Research (ICMR), Indian Council of Agricultural Research (ICAR), and Council of Scientific and Industrial Research (CSIR). Recently, the National Institute of Biologicals (NIB) was also established in New Delhi to conduct research, manufacturing and clinical studies.

WHY HYDERABAD, ANDHRA PRADESH?

• Hyderabad is a significant IT and Pharma industry hub of India and it is also a renowned center of learning. Andhra has among the largest resource pool of qualified and trained scientists and engineers educated in several technical and engineering institutions spread throughout the state.